In June 2012, the Growth Enterprise Board Public Offering Review Committee of the China Securities Regulatory Commission approved the ChiNext public listing of Zhejiang Wolwo Bio-Pharmaceutical Inc..

Llinks advised this project as the legal counsel to the Issuer, Zhejiang Wolwo Bio-Pharmaceutical Inc..